Confirmed six-month disability progression rates over 4 years were similar in patients given the oral statin or a placebo in ...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE ...

Gaps in access to care persist for US patients with MS and impact HRQOL to a large extent. Improving access to care for patients with MS should be prioritized.

BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced the acceptance of two abstracts featuring NurOwn® (MSC-NTF or ...

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...

These "fixes" include lifestyle modifications, pelvic floor exercises, fluid management, and the appropriate use of ...

The new report follows the release earlier this month of data from US states and territories that showed that in 2023, the ...

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted ...

Longevity is becoming increasingly popular to elongate health-span. We turn to estrogen to understand its impact on women's ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that CEO ...

More and more research suggests that gut microbiome metabolites could hold the key to treating nearly every disease.

Very often the biggest decisions in life occur by chance. I went into gastroenterology when I was still very young, starting ...